RIVER OAKS HOSPITAL
1. Target Overview & Investment Thesis
RIVER OAKS HOSPITAL is a 158-bed safety-net/medicaid heavy in RANKIN, MS with $124.1M in net patient revenue and a 7.0% operating margin. The hospital serves a payer mix of 19.6% Medicare, 27.3% Medicaid, and 53.1% commercial.
Thesis: Turnaround. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.0% to 14.3% (+736bps).
| Net Revenue HCRIS | $124.1M |
| Current EBITDA COMPUTED | $8.7M |
| Operating Margin COMPUTED | 7.0% |
| Occupancy HCRIS | 32.6% |
| Revenue / Bed COMPUTED | $785K |
| Net-to-Gross HCRIS | 8.9% |
| Distress Probability ML | 56.1% |
2. Market Context & Competitive Position
MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 7.0% places it above the state median. Among 29 size-comparable peers (79-316 beds), the median margin is -4.7%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (79-316), prioritizing same-state peers. 29 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RIVER OAKS HOSPITAL (Target) | MS | 158 | $124.1M | 7.0% |
| MEMORIAL HOSPITAL AT GULFPORT | MS | 278 | $700.2M | -15.7% |
| SINGING RIVER HEALTH SYSTEM | MS | 294 | $415.9M | -12.8% |
| BAPTIST MEM HOSPITAL DESOTO | MS | 298 | $301.6M | -5.2% |
| BAPTIST MEM HOSPITAL NORTH MIS | MS | 195 | $229.4M | 0.7% |
| BAPTIST MEM HOSPITAL GOLDEN TR | MS | 154 | $221.1M | 6.9% |
| JEFF ANDERSON REGIONAL MEDICAL | MS | 270 | $213.3M | -25.9% |
| MAGNOLIA HOSPITAL | MS | 158 | $161.6M | -4.7% |
| SOUTH CENTRAL REGIONAL MEDICAL | MS | 268 | $146.9M | -1.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $79K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $8.7M |
| + RCM Uplift | +$9.1M |
| Pro Forma EBITDA | $17.8M |
| Current Margin | 7.0% |
| Pro Forma Margin | 14.3% |
| WC Released (1x) | $4.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $13.3M | $148.5M | 11.14x | 62.0% |
| Base (11x exit) | 10.0x | 11.0x | $13.3M | $167.6M | 12.58x | 65.9% |
| Bull Case | 9.0x | 11.0x | $12.0M | $202.1M | 16.85x | 75.9% |
| Bull (12x exit) | 9.0x | 12.0x | $12.0M | $224.0M | 18.68x | 79.6% |
| Bear Case | 11.0x | 10.0x | $14.7M | $98.5M | 6.72x | 46.4% |
| Bear (11x exit) | 11.0x | 11.0x | $14.7M | $113.1M | 7.71x | 50.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (27.3%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Medium | Low occupancy | At 32.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 56.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 29 hospitals with 79-316 beds
- Same-state prioritization (n=30)
- Comp margins: P25=-15.7% / P50=-4.7% / P75=1.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.